Bank of Hawaii’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bank of Hawaii’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,986	Closed	-$535K	–	255
2023 Q1	$535K	Buy	4,986 +1,275	+34%	+$147K	0.03%	178
2022 Q4	$408K	Buy	+3,711	New	+$241K	0.03%	197

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Bank of Hawaii's RXDX Position: Q2 2023 in Review

Bank of Hawaii sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 4,986 shares — an estimated $535K sold.

Bank of Hawaii first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $535K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Bank of Hawaii reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bank of Hawaii sold 4,986 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $535K.
Bank of Hawaii first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Bank of Hawaii's Prometheus Biosciences, Inc. Common Stock position peaked at $535K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Bank of Hawaii's 13F filing for Q2 2023, filed 10 Aug 2023.